We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Microchip Test Identifies Antibiotic-Resistant Bacteria

By HospiMedica staff writers
Posted on 11 Sep 2007
A microchip test quickly and inexpensively identifies dangerous drug resistant bacteria in clinical samples.

The miniaturized microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhea-causing Escherichia coli and Salmonella, which causes food poisoning. More...


In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests also identified unique and previously unknown combinations of virulence genes, whose significance has not yet been determined.

Physicians and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, and receive the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in E. coli bacteria and 54 antimicrobial resistance genes covering all the known families of Gram-negative bacteria,” said Dr. Muna Anjum from the UK Veterinary Laboratories Agency in Addlestone (UK) where the new test was developed. "Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals, and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals.”

The microchip technology will allow scientists to search for and identify important genes from other pathogens and bacteria, such as genes that may be commercially important in industrial processes such as food processing, pharmaceutical development and waste handling.

The scientists presented their new test at the Society for General Microbiology's 161st meeting, which took place at the University of Edinburgh (Edinburgh, UK), on September 3-6, 2007.


Related Links:
University of Edinburgh
UK Veterinary Laboratories Agency in Addlestone

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.